The Harry Glorikian Show

Harry Glorikian

At The Harry Glorikian Show, I, Harry Glorikian, am your host. In short, I have talks with leaders in the healthcare & life sciences industry about the ongoing data-driven transformation of their industry. From new ways to diagnose & treat patients, bring down costs & creating new value, all the way to AI algorithms that increase efficiency & accuracy, better data is revolutionizing healthcare. I turn to doctors, hospital administrators, IT directors, entrepreneurs, & others for help mapping out the changes & their impact on everyone from patients to researchers. Welcome to the show!

  1. 3d ago

    Butterfly Network's Next Chip: Joe DeVivo Returns on AI, Ultrasound & the Path from Prototype to Product

    Three years after his first appearance, Butterfly Network CEO Joe DeVivo returns to catch Harry up on the roadmap. Butterfly's ultrasound-on-a-chip has evolved from a single handheld device into a foundational semiconductor platform that third parties can build on. The most dramatic example: Midjourney's full-body scanner, which rings 40 Butterfly chips around the body for whole-body tomographic imaging. Joe and Harry dig into what's real today versus what's coming, the physics of ultrasound, the path from demo to FDA clearance, and the business logic of "multiple shots on goal."   In this episode:   The chip as a platform: opening Butterfly's technology to third-party developers (the "Nvidia moment").   Midjourney's full-body scanner: tomography, 400 teraflops of data, and a roadmap toward a one-minute scan with the Apollo chip.   Real-world impact: 1,500 midwives trained in Kenya and South Africa, plus a new FDA-cleared gestational-age AI tool.   Partners beyond Midjourney: vascular robotics, fatty liver diagnosis, and brain-computer interfaces (including "silent speech").   Physics Q&A: why 360-degree imaging solves ultrasound's problems with air and bone.   The hospital shift: capturing "ghost" scans, Compass AI, and at-risk skilled-nursing deployments.   The 10-year vision: imaging that comes to the patient instead of the patient going to imaging.   Chapters:   (00:01) A roadmap from three years ago (00:31) Midjourney unveils a full-body scanner (01:31) Joe DeVivo returns (02:59) What shipped: the chip becomes foundational (04:52) Opening the platform to third parties (06:34) Kenya and South Africa: midwives and the FDA-cleared gestational-age app (11:11) FDA rigor and validating AI (14:52) Butterfly Garden, Butterfly Embedded, and the nine partners (16:53) Brain-computer interfaces and silent speech (22:00) The Midjourney deal: origin and reaction (24:03) Tomography explained (28:12) What 40 chips can see and the data challenge (29:33) The roadmap to a one-minute scan; the Apollo chip (32:43) AI looking for a physical carrier (34:31) Prototype to product: milestones to clearance (38:28) Wellness first, then regulatory clearances (39:03) The physics of air and bone (41:45) The investment thesis: multiple shots on goal (46:26) The business today: Compass AI and health-system deployments (49:54) Heart-failure monitoring and at-risk skilled nursing (53:49) The 10-year view: imaging comes to the patient (57:18) Why early detection matters (59:50) Closing   About the guest: Joe DeVivo is CEO of Butterfly Network and has spent 35 years in medical devices.   Also mentioned: Harry's book, The Invisible Interface: How AI Turns Intentions into Actions and Who Wins (foreword by Don Norman), available in print and ebook.

    Butterfly Network's Next Chip: Joe DeVivo Returns on AI, Ultrasound & the Path from Prototype to Product
  2. 02/11/2025

    Al's Transformative Role in Pharma ConcertAl CEO Jeff Elton

    In this episode of The Harry Glorikian Show, host Harry Glorikian welcomes back Jeff Elton, CEO of Concert AI, to discuss the latest advancements in AI-driven healthcare solutions. They reflect on the recent JP Morgan Healthcare Conference, highlighting the optimism surrounding AI's role in transforming drug development and oncology. Jeff shares insights into Concert AI's innovative data ecosystems, partnerships, and the introduction of Kera, an AI platform designed to enhance clinical decision-making. The conversation also explores the challenges and opportunities in the evolving landscape of healthcare technology, emphasizing the importance of collaboration and adaptability in the face of rapid change. Takeaways: The JP Morgan Healthcare Conference indicated a positive outlook for the industry. AI is becoming a central theme in healthcare discussions. Concert AI is developing a comprehensive data ecosystem for oncology. The introduction of agentic AI models is set to revolutionize data processing. Collaboration with NVIDIA is enhancing Concert AI's capabilities. Kera is a significant advancement in AI-driven healthcare solutions. The future of drug development will rely heavily on AI and data analytics. Healthcare organizations must adapt to the rapid pace of technological change. Building partnerships is crucial for addressing healthcare fragmentation. The integration of AI in clinical trials can significantly reduce timelines. Chapters   00:00 The Annual Healthcare Pilgrimage 03:19 Optimism in the Pharma Industry 06:07 The Rise of AI in Healthcare 10:03 Concert AI's Evolution and Innovations 15:10 2024: A Standout Year for Concert AI 18:55 Balancing Growth and Innovation 22:33 Scaling Across Therapeutic Areas 26:26 The Future of Collaborations in Healthcare 28:37 Integrating Immune Status and Data Collaboration 31:04 Introducing Kera AI: The Future of Data Management 35:24 Innovations in Clinical Trials and Data Solutions 40:16 Rethinking Drug Development: Digital Twins and AI 42:36 Navigating Market Shifts and Talent Challenges 54:02 The Future of Concert AI and Healthcare Solutions

    Al's Transformative Role in Pharma ConcertAl CEO Jeff Elton
  3. 04/09/2024

    Raffi Krikorian Says "We Don't Have Much Time Left" to Rein in AI

    Harry's guest this week is Raffi Krikorian, chief technology officer and managing director at Emerson Collective, the social change organization founded by Laurene Powell Jobs. Krikorian is the former vice president of engineering at Twitter (now X), where he was responsible for getting rid of the Fail Whale and making the company’s backend infrastructure more reliable; the former director of Uber's Advanced Technology Center in Pittsburgh, where he oversaw the launch of the world's first fleet of self-driving cars; and then the chief technology officer at the Democratic National Committee, where he helped rebuild the party's technology infrastructure after the Russian hacking debacle of 2016. At Emerson Collective, Krikorian built the technology organization, leads the development of data products, and works to upgrade the back offices of the non-profits Emerson works with. On top of all that, he recently launched a podcast called Technically Optimistic, where he’s taking a deep dive into the way AI is challenging us all to think differently about the future of work, education, policy, regulation, creativity, copyright, and many other areas. The show is a must-listen for anyone who cares about how we can build on AI to transform society for the better while minimizing the collateral damage. Harry talked with Krikorian about why he moved to Emerson Collective, why and how he started the podcast, and what he really thinks about what government should be doing to prepare for the waves of social change AI will bring. For a full transcript of this episode, please visit our episode page at http://www.glorikian.com/podcast  Please rate and review The Harry Glorikian Show on Apple Podcasts or Spotify!  Here's how to do that on Apple Podcasts: 1. Open the Podcasts app on your iPhone, iPad, or Mac.  2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode. 3. Scroll down to find the subhead titled "Ratings & Reviews." 4. Under one of the highlighted reviews, select "Write a Review." 5. Next, select a star rating at the top — you have the option of choosing between one and five stars.  6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long. 7. Once you've finished, select "Send" or "Save" in the top-right corner.  8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out.  9. After selecting a nickname, tap OK. Your review may not be immediately visible. On Spotify, the process is similar. Open the Spotify app, navigate to The Harry Glorikian Show, tap the three dots, then tap "Rate Show." Thanks!

    Raffi Krikorian Says "We Don't Have Much Time Left" to Rein in AI
4.9
out of 5
56 Ratings

About

At The Harry Glorikian Show, I, Harry Glorikian, am your host. In short, I have talks with leaders in the healthcare & life sciences industry about the ongoing data-driven transformation of their industry. From new ways to diagnose & treat patients, bring down costs & creating new value, all the way to AI algorithms that increase efficiency & accuracy, better data is revolutionizing healthcare. I turn to doctors, hospital administrators, IT directors, entrepreneurs, & others for help mapping out the changes & their impact on everyone from patients to researchers. Welcome to the show!